# VOR BIOPHARMA INC (VOR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/VOR/

- Reporting holders: 3
- Reported value: $30.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $13.9K | 728 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $10.0K | 522 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $6.4K | 337 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $30.3K |
| Q2 2026 | 103 | $963.3M |
| Q1 2026 | 80 | $721.2M |
| Q4 2025 | 56 | $354.1M |
| Q3 2025 | 40 | $599.5M |
| Q2 2025 | 3 | $3.2M |
| Q1 2025 | 3 | $74.7K |
| Q4 2024 | 2 | $65.2K |
| Q3 2024 | 1 | $6.9K |
| Q2 2024 | 1 | $14.3K |
| Q1 2024 | 1 | $33.9K |
| Q3 2023 | 1 | $4.2K |